Cutaneous leishmaniasis continues to be a diagnostic and therapeutic problem in endemic areas. History and epidemiology of the disease, the causative organism, and the mode of transmission are discussed. The nature of the immune response is outlined and the finding of circulating antibodies in the sera of patients is reported. A classification of cutaneous leishmaniasis is proposed, and clinical and histopathological descriptions are detailed. Therapeutic measures are critically reviewed.
Farah FS, Malak JA. Cutaneous Leishmaniasis. Arch Dermatol. 1971;103(5):467–474. doi:10.1001/archderm.1971.04000170001001
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: